Log in to search using one of your social media accounts:


PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY

Condition:   Breast Neoplasms Interventions:   Drug: Palbociclib;   Drug: Placebo;   Drug: Tamoxifen;   Drug: Goserelin Sponsors:   National Cancer Center, Japan;   Pfizer;   Korean Cancer Study Group Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials

Related Links:

More News: Breast Cancer | Cancer | Cancer & Oncology | HER2 | Hormones | Japan Health | Pfizer | Research | Study | Tamoxifen | Women